Displaying 222 results out of a total of 3930 publications.
Abstract P5-21-16: Preclinical studies of RX-5902, a beta-catenin modulator in triple negative breast cancer
Tentler, J;Frank, J;Kim, D;George, C;Lee, Y;Ely, B;Tan, A;Kim, J;Pitts, T;Capasso, A;Dailey, K;Eckhardt, G;Diamond, J;
Cancer Res, Cancer Res 78(4 Supplement):P5-21-16-P5-21-16, 2018
View publication
Cancer Res, Cancer Res 78(4 Supplement):P5-21-16-P5-21-16, 2018
Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK2 Inhibitor for Treatment of Triple-negative Breast Cancer with a Compromised G1/S Checkpoint
Zhu, D;Xu, S;Deyanat-Yazdi, G;Peng, SX;Barnes, LA;Narla, RK;Tran, T;Mikolon, D;Ning, Y;Shi, T;Jiang, N;Raymon, HK;Riggs, JR;Boylan, JF;
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2018
View publication
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2018
RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development
Zhang, X;Dowling, JP;Zhang, J;
Cell Death Dis, Cell Death Dis 10(3):245, 2019
View publication
Cell Death Dis, Cell Death Dis 10(3):245, 2019
Novel Dual-Action Prodrug Triggers Apoptosis in Glioblastoma Cells by Releasing a Glutathione Quencher and Lysine-specific Histone Demethylase 1A Inhibitor
Engel, M;Gee, YS;Cross, D;Maccarone, A;Heng, B;Hulme, A;Smith, G;Guillemin, GJ;Stringer, BW;Hyland, CJT;Ooi, L;
J. Neurochem., J. Neurochem. ():, 2018
View publication
J. Neurochem., J. Neurochem. ():, 2018
Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5
Kleemann, M;Schneider, H;Unger, K;Bereuther, J;Fischer, S;Sander, P;Marion Schneider, E;Fischer-Posovszky, P;Riedel, CU;Handrick, R;Otte, K;
Cell. Mol. Life Sci., Cell. Mol. Life Sci. ():, 2018
View publication
Cell. Mol. Life Sci., Cell. Mol. Life Sci. ():, 2018
Cabozantinib exhibits potent antitumor activity in colorectal cancer patient-derived tumor xenograft models via autophagy and signaling mechanisms
Scott, AJ;Arcaroli, JJ;Bagby, SM;Yahn, R;Huber, KM;Serkova, NJ;Nguyen, A;Kim, J;Thorburn, A;Vogel, J;Quackenbush, KS;Capasso, A;Schreiber, A;Blatchford, P;Klauck, PJ;Pitts, TM;Eckhardt, SG;Messersmith, WA;
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2018
View publication
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2018
NKL homeobox gene NKX2-2 is aberrantly expressed in Hodgkin lymphoma
Nagel, S;MacLeod, RAF;Pommerenke, C;Meyer, C;Kaufmann, M;Drexler, HG;
Oncotarget, Oncotarget 9(101):37480-37496, 2018
View publication
Oncotarget, Oncotarget 9(101):37480-37496, 2018
Death by HDACinhibition in synovial sarcoma cells
Laporte, AN;Poulin, NM;Barrott, JJ;Wang, XQ;Lorzadeh, A;Vander Werff, R;Jones, KB;Underhill, TM;Nielsen, TO;
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2017
View publication
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2017
TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation
Malireddi, RKS;Gurung, P;Mavuluri, J;Dasari, TK;Klco, JM;Chi, H;Kanneganti, TD;
J. Exp. Med., J. Exp. Med. ():, 2018
View publication
J. Exp. Med., J. Exp. Med. ():, 2018
Therapeutic potential of ghrelin and des-acyl ghrelin against chemotherapy-induced cardiotoxicity
Nonaka, M;Kurebayashi, N;Murayama, T;Sugihara, M;Terawaki, K;Shiraishi, S;Miyano, K;Hosoda, H;Kishida, S;Kangawa, K;Sakurai, T;Uezono, Y;
Endocr. J., Endocr. J. 64(Suppl.):S35-S39, 2017
View publication
Endocr. J., Endocr. J. 64(Suppl.):S35-S39, 2017